Novo Nordisk Launches $149 Wegovy Pill, Expanding Access to GLP-1 Weight-Loss DrugsJan 5DecryptHealthImpact
Novo Nordisk enters 2026 on the defense as it faces a ‘must-win’ battle in the U.S. marketJan 1CNBCeconomics
Novo Nordisk's 'long game' on weight loss drugs sparks hope in science, but the Street is impatientDec 30CNBCScience
A cheaper, easier-to-use version of Wegovy is coming to the US soonDec 23Business InsiderHealthImpact